In prostate cancer, upregulation of p22phox was also reported to activate PI3K/Akt pathway and extracellular signal-regulated kinase 1/2 (ERK1/2) pathway and subsequently induce HIF-1α via ROS signaling [16]. This evidence concerns the gene CYBA and prostate carcinoma.